General
Divi's Laboratories to invest Rs. 1,500 Cr for setting up new facility in Andhra Pradesh
The company has received all the requisite licenses from the Government of India and Government of Andhra Pradesh for implementation of the project
- By ICN Bureau
| December 03, 2020
Divi's Laboratories Limited will be investing about Rs. 1,500 crores out of its internal accruals in phased manner for the implementation of its Unit-III facility.
Divi's Laboratories has started commencement construction of Unit-III Facility at Kona Forest, Ontimamidi Village, Thondangi Mandal, Near Kakinada, East Godavari District, Andhra Pradesh from 7th December, 2020.
The operations are likely to commence within 12 to 18 months for 1st phase of the Unit-III Project. The company has received all the requisite licenses from the Government of India and Government of Andhra Pradesh for implementation of the Project.
Divi’s is recognized as a reliable supplier of generic APIs (Active Pharmaceuticals Ingredients)’ and a trustworthy Custom Manufacturer to big Pharma and also is among the top API manufacturers in the world. The company is the leading manufacturer of APIs, Intermediates and Registered Starting Materials offering high quality products with the highest level of compliance and integrity to over 95 countries.
Register Now to Attend Gujarat Chem & Petchem Conference 2025 on May 8-9th 2025, at Hyatt Place, Bharuch
Register Now to Attend NextGen Chemicals & Petrochemicals Summit 2025 on June 18-19th 2025, The Leela Mumbai
